The proof you need before your next raise, your next audit and your next board meeting.
Written for HealthTech founders who need to speak fluently about funding stages, payer and provider buying cycles, regulatory reality and clinical evidence, because your next investor, partner or procurement committee will.
How to market a HealthTech startup between seed and Series A
The eighteen months between your seed round and your Series A are not about brand awareness. They are about proving that demand is not an accident. Here is the sequence that actually gets funded.
What investors actually look for in your traction story
Most HealthTech decks lead with logos and downloads. Investors diligencing a HealthTech raise are reading for something else entirely: whether your growth is structural or borrowed. Here is what they actually check.
Marketing a regulated HealthTech product without breaking compliance
The moment your product touches a regulated claim, whether that is FDA clearance, CE marking or a clinical outcome, your marketing team inherits legal exposure. Most HealthTech marketing teams learn this the hard way. Here is how to build the discipline in from the start.
Clinical evidence as a growth asset, not a compliance cost
Most HealthTech founders treat clinical evidence as a box to tick for regulators or a slow academic exercise that marketing waits on. The companies that grow fastest treat evidence generation as a growth function with its own roadmap, timed to unlock specific buyers.
Is your growth story ready for your next raise?
Score your positioning, pipeline evidence, clinical proof and market narrative in two minutes.
Take the raise readiness assessmentTurn this proof into a funded, compliant growth engine.
Book a call and we will map which of these playbooks matters most for your stage right now.
required
24 hours
worldwide
Choose a date
Loading availability